Effective 7/25/2007, Alteon Inc. became Synvista Therapeutics, Inc.
We are currently updating our website.

Any statements contained in this web site that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, those relating to technology and product development, regulatory approval processes, intellectual property rights and litigation, competitive products, ability to obtain financing, and other risks identified in Synvista's filings with the Securities and Exchange Commission. The information contained in each section of the website is accurate as of the date indicated. Actual results, events or performances may differ materially. Synvista undertakes no obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstance after the date hereof or to reflect the occurrence of unanticipated events.